This Month at BKI | Breaking News from the BKI

BKI in the News

• BKI research leads to FDA approval for Merkel Cell Cancer (ASCO, December 18, 2018)
• Johns Hopkins Kimmel Cancer Center Immunotherapy Experts Named Bloomberg~Kimmel Professors (December 10, 2018)
• Disease Activity in Circulating Tumor DNA Predicts Melanoma Progression (November 27, 2018)
• Unraveling a Medical Mystery: a multidisciplinary team of physicians piece together a diagnosis for a patient with an an uncommon condition (Johns Hopkins Medicine Suburban, Fall 2018)
• Neoadjuvant Immunotherapy Emerges as a New Frontier (OncLive.com, August 20, 2018)
• PD-1 blockade provides "dramatic advance" for the treatment of advanced melanoma (August 13, 2018)
• Lethal Prostate Cancer Treatment May Benefit from Combination Immunotherapy (Science Daily, June 25, 2018)
• New State-of-the-Art Clinic for Immunotherapy (WBAL-TV, May 8, 2018)

Multimedia

• Dr. Bill Nelson and Dr. Drew Pardoll discuss recent advances in immunotherapy in the latest Cancer Matters podcast (August 2, 2018)
• Dr. Drew Pardoll shares insights from the 2018 ACSO conference with Bloomberg TV (June 8, 2018)
• Bloomberg Radio's Tom Keene discusses the impact of immunotherapy with Dr. Drew Pardoll (June 7, 2018)